195 related articles for article (PubMed ID: 24496317)
1. Herpes simplex virus type-2 stimulates HIV-1 replication in cervical tissues: implications for HIV-1 transmission and efficacy of anti-HIV-1 microbicides.
Rollenhagen C; Lathrop MJ; Macura SL; Doncel GF; Asin SN
Mucosal Immunol; 2014 Sep; 7(5):1165-74. PubMed ID: 24496317
[TBL] [Abstract][Full Text] [Related]
2. The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment.
Seay K; Khajoueinejad N; Zheng JH; Kiser P; Ochsenbauer C; Kappes JC; Herold B; Goldstein H
J Virol; 2015 Sep; 89(18):9559-70. PubMed ID: 26157126
[TBL] [Abstract][Full Text] [Related]
3. Enhancing Interferon Regulatory Factor 7 Mediated Antiviral Responses and Decreasing Nuclear Factor Kappa B Expression Limit HIV-1 Replication in Cervical Tissues.
Rollenhagen C; Macura SL; Lathrop MJ; Mackenzie TA; Doncel GF; Asin SN
PLoS One; 2015; 10(6):e0131919. PubMed ID: 26121689
[TBL] [Abstract][Full Text] [Related]
4. Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes.
LeGoff J; Weiss HA; Gresenguet G; Nzambi K; Frost E; Hayes RJ; Mabey DC; Malkin JE; Mayaud P; Belec L
AIDS; 2007 Jul; 21(12):1569-78. PubMed ID: 17630552
[TBL] [Abstract][Full Text] [Related]
5. Tenofovir Gel for Prevention of Herpes Simplex Virus Type 2 Acquisition: Findings From the VOICE Trial.
Marrazzo JM; Rabe L; Kelly C; Richardson B; Deal C; Schwartz JL; Chirenje ZM; Piper J; Morrow RA; Hendrix CW; Marzinke MA; Hillier SL;
J Infect Dis; 2019 May; 219(12):1940-1947. PubMed ID: 30753642
[TBL] [Abstract][Full Text] [Related]
6. Blocking CXCL9 Decreases HIV-1 Replication and Enhances the Activity of Prophylactic Antiretrovirals in Human Cervical Tissues.
Macura SL; Lathrop MJ; Gui J; Doncel GF; Asin SN; Rollenhagen C
J Acquir Immune Defic Syndr; 2016 Apr; 71(5):474-82. PubMed ID: 26545124
[TBL] [Abstract][Full Text] [Related]
7. Progesterone augments cell susceptibility to HIV-1 and HIV-1/HSV-2 co-infections.
Ragupathy V; Xue W; Tan J; Devadas K; Gao Y; Hewlett I
J Mol Endocrinol; 2016 Oct; 57(3):185-99. PubMed ID: 27538988
[TBL] [Abstract][Full Text] [Related]
8. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus.
Nagot N; Ouédraogo A; Foulongne V; Konaté I; Weiss HA; Vergne L; Defer MC; Djagbaré D; Sanon A; Andonaba JB; Becquart P; Segondy M; Vallo R; Sawadogo A; Van de Perre P; Mayaud P;
N Engl J Med; 2007 Feb; 356(8):790-9. PubMed ID: 17314338
[TBL] [Abstract][Full Text] [Related]
9. Altered HIV-1 Viral Copy Number and Gene Expression Profiles of Peripheral (CEM CCR5+) and Mucosal (A3R5.7) T Cell Lines Co-Infected with HSV-2 In Vitro.
Desai D; Londhe R; Chandane M; Kulkarni S
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016337
[TBL] [Abstract][Full Text] [Related]
10. Multipurpose tenofovir disoproxil fumarate electrospun fibers for the prevention of HIV-1 and HSV-2 infections in vitro.
Tyo KM; Vuong HR; Malik DA; Sims LB; Alatassi H; Duan J; Watson WH; Steinbach-Rankins JM
Int J Pharm; 2017 Oct; 531(1):118-133. PubMed ID: 28797967
[TBL] [Abstract][Full Text] [Related]
11. The Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal Applications.
Gordts SC; Férir G; D'huys T; Petrova MI; Lebeer S; Snoeck R; Andrei G; Schols D
PLoS One; 2015; 10(7):e0131219. PubMed ID: 26132818
[TBL] [Abstract][Full Text] [Related]
12. The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase.
Andrei G; Gillemot S; Topalis D; Snoeck R
J Infect Dis; 2018 Feb; 217(5):790-801. PubMed ID: 29186456
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring.
Moss JA; Malone AM; Smith TJ; Kennedy S; Kopin E; Nguyen C; Gilman J; Butkyavichene I; Vincent KL; Motamedi M; Friend DR; Clark MR; Baum MM
Antimicrob Agents Chemother; 2012 Feb; 56(2):875-82. PubMed ID: 22123689
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus type 2-infected dendritic cells produce TNF-α, which enhances CCR5 expression and stimulates HIV production from adjacent infected cells.
Marsden V; Donaghy H; Bertram KM; Harman AN; Nasr N; Keoshkerian E; Merten S; Lloyd AR; Cunningham AL
J Immunol; 2015 May; 194(9):4438-45. PubMed ID: 25840914
[TBL] [Abstract][Full Text] [Related]
15. A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2.
Vanpouille C; Lisco A; Derudas M; Saba E; Grivel JC; Brichacek B; Scrimieri F; Schinazi R; Schols D; McGuigan C; Balzarini J; Margolis L
J Infect Dis; 2010 Feb; 201(4):635-43. PubMed ID: 20085496
[TBL] [Abstract][Full Text] [Related]
16. 5-Hydroxytyrosol inhibits HIV-1 replication in primary cells of the lower and upper female reproductive tract.
Saba E; Panina-Bordignon P; Pagani I; Origoni M; Candiani M; Doglioni C; Taccagni G; Ghezzi S; Alcami J; Vicenzi E; Poli G
Antiviral Res; 2017 Jun; 142():16-20. PubMed ID: 28286236
[TBL] [Abstract][Full Text] [Related]
17. The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice.
Donalisio M; Quaranta P; Chiuppesi F; Pistello M; Cagno V; Cavalli R; Volante M; Bugatti A; Rusnati M; Ranucci E; Ferruti P; Lembo D
Biomaterials; 2016 Apr; 85():40-53. PubMed ID: 26854390
[TBL] [Abstract][Full Text] [Related]
18. Real-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV.
Legoff J; Bouhlal H; Grésenguet G; Weiss H; Khonde N; Hocini H; Désiré N; Si-Mohamed A; de Dieu Longo J; Chemin C; Frost E; Pépin J; Malkin JE; Mayaud P; Bélec L
J Clin Microbiol; 2006 Feb; 44(2):423-32. PubMed ID: 16455895
[TBL] [Abstract][Full Text] [Related]
19. Genital herpes simplex virus type 2 infection in humanized HIV-transgenic mice triggers HIV shedding and is associated with greater neurological disease.
Nixon B; Fakioglu E; Stefanidou M; Wang Y; Dutta M; Goldstein H; Herold BC
J Infect Dis; 2014 Feb; 209(4):510-22. PubMed ID: 23990571
[TBL] [Abstract][Full Text] [Related]
20. Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication.
Andrei G; Lisco A; Vanpouille C; Introini A; Balestra E; van den Oord J; Cihlar T; Perno CF; Snoeck R; Margolis L; Balzarini J
Cell Host Microbe; 2011 Oct; 10(4):379-89. PubMed ID: 22018238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
